Profile
Gunnar Modalen worked as Chief Financial Officer & Head-Investor Relations at Doro AB and as Chief Financial Officer at Viking Supply Ships AB. He also worked as Information & Investor Relations Officer at Cherry AB and as Chief Financial Officer at Simris Group AB. From 2017 to 2021, he worked as Chief Financial Officer at ISR Immune System Regulation Holding AB. Mr. Modalen completed his undergraduate degree at the University of Lund.
Former positions of Gunnar Modalen
| Companies | Position | End |
|---|---|---|
| ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Director of Finance/CFO | 01/01/2021 |
| CHERRY AB (PUBL) | Chief Tech/Sci/R&D Officer | 04/04/2017 |
| SIMRIS GROUP AB | Director of Finance/CFO | - |
| DORO AB | Director of Finance/CFO | - |
| VIKING SUPPLY SHIPS AB | Director of Finance/CFO | - |
Training of Gunnar Modalen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Doro AB
Doro AB Telecommunications EquipmentElectronic Technology Manufactures and distributes senior-friendly phones and mobile phones | Electronic Technology |
Viking Supply Ships AB
Viking Supply Ships AB Marine ShippingTransportation Provides ship management and marine transportation services to the offshore oil and gas industry | Transportation |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cherry AB
Cherry AB Movies/EntertainmentConsumer Services Operates online casinos, sports betting and lottery activities | Consumer Services |
Simris Group AB
Simris Group AB BiotechnologyHealth Technology Operates as biotechnology company, which develops and manufactures biologically active substances microalgae | Health Technology |
ISR Immune System Regulation Holding AB
ISR Immune System Regulation Holding AB Pharmaceuticals: MajorHealth Technology Develops immunostimulating medicinal products | Health Technology |
- Stock Market
- Insiders
- Gunnar Modalen
















